Research Achievements - Original paper -
-
Ramelteon for Delayed Sleep-wake Phase Disorder: A Case Report.
Takeshima M, Shimizu T, Ishikawa H, Kanbayashi T.
Clinical psychopharmacology and neuroscience 18 ( 1 ) 167 - 169 2020.02 [Refereed]
Research paper (journal) Domestic Co-author
-
Prevalence of asymptomatic venous thromboembolism in depressive inpatients
Takeshima M.
Neuropsychiatric Disease and Treatment ( Neuropsychiatric Disease and Treatment ) 16 579 - 587 2020.02 [Refereed]
Research paper (journal) Domestic Co-author
-
A Multi-center Questionnaire Survey on the Management and Treatment of Epilepsy in Akita
Shibata Ken-ichi, Yano Tamami, Okawa Satoshi, Takeshima Masahiro, Shimizu Hiroaki
Journal of the Japan Epilepsy Society ( JAPAN EPILEPSY SOCIETY ) 37 ( 3 ) 779 - 787 2020.01 [Refereed]
Research paper (journal) Domestic Co-author
<p>There are few epilepsy specialists in Akita, and non-specialists manage and treat most of the epilepsy patients. This study surveyed the actual state of the management and treatment for epilepsy in Akita. We conducted a questionnaire survey of 97 medical doctors in four different departments at 35 institutions. The questionnaire contained 24 items regarding the number of patients, type of the tests and treatments conducted, and issues regarding the management and treatment for epilepsy. Completed surveys were obtained from 47 medical doctors. Symptomatic localization-related epilepsy was common. Cerebrovascular disease was the most frequent cause. Evaluation of electroencephalography and magnetic resonance imaging performed in more than 90% of patients contributed to diagnosis of epilepsy. Seizures were well controlled by antiepileptic drugs in 90% of patients. Levetiracetam was selected most often for localization-related epilepsy, followed by carbamazepine and lamotrigine. Valproic acid was selected most often for generalized epilepsy, followed by levetiracetam and lamotrigine. Issues in the management and treatment for epilepsy included difficulties in the interpretation of electroencephalography and the lack of local epilepsy specialists.</p>
-
Long-term use of hypnotics: Analysis of trends and risk factors
Enomoto M.
General Hospital Psychiatry ( General Hospital Psychiatry ) 62 49 - 55 2020.01 [Refereed]
Research paper (journal) Domestic Co-author
-
Yamamoto M.
Neuropsychopharmacology Reports ( Neuropsychopharmacology Reports ) 41 ( 1 ) 14 - 25 2020 [Refereed]
Research paper (journal) Domestic Co-author
-
Ono H.
Sleep and Biological Rhythms ( Sleep and Biological Rhythms ) 17 ( 1 ) 123 - 140 2019.01 [Refereed]
Research paper (journal)
-
Gabapentin enacarbil for antipsychotic induced akathisia in schizophrenia patients: a pilot open-labeled study.
Takeshima M, Ishikawa H, Kanbayashi T, Shimizu T.
Neuropsychiatric disease and treatment 14 3179 - 3184 2018.11 [Refereed]
Research paper (journal) Domestic Co-author
-
Inpatient phase-advance therapy for delayed sleep-wake phase disorder: a retrospective study.
Takeshima M, Shimizu T, Echizenya M, Ishikawa H, Kanbayashi T.
Nature and science of sleep 10 327 - 333 2018.10 [Refereed]
Research paper (journal) Domestic Co-author
-
Successful management of clozapine-induced akathisia with gabapentin enacarbil: A case report
Takeshima M.
Clinical Psychopharmacology and Neuroscience ( Clinical Psychopharmacology and Neuroscience ) 16 ( 3 ) 346 - 348 2018.08 [Refereed]
Research paper (journal) Domestic Co-author
-
A case of perampanel-induced delirium in a patient with symptomatic epilepsy.
Takeshima M, Ishikawa H, Ono T, Kanbayashi T, Shimizu T.
Seizure 2018.05 [Refereed]
Research paper (journal) Domestic Co-author
-
A case of perampanel-induced delirium in a patient with symptomatic epilepsy
Takeshima M.
Seizure ( Seizure ) 58 154 - 155 2018.05 [Refereed]
Research paper (journal) Domestic Co-author
-
Anorexia nervosa-associated pancytopenia mimicking idiopathic aplastic anemia: A case report
Takeshima M.
BMC Psychiatry ( BMC Psychiatry ) 18 ( 1 ) 2018.05 [Refereed]
Research paper (journal) Domestic Co-author
-
Incidence of venous thromboembolism in psychiatric inpatients: A chart review
Takeshima M.
Neuropsychiatric Disease and Treatment ( Neuropsychiatric Disease and Treatment ) 14 1363 - 1370 2018.05 [Refereed]
Research paper (journal) Domestic Co-author
-
Omori Y.
Neuropsychiatric Disease and Treatment ( Neuropsychiatric Disease and Treatment ) 14 1281 - 1286 2018.05 [Refereed]
Research paper (journal) International Co-author
-
Successful management of clozapine-induced restless legs syndrome with gabapentin enacarbil.
Hosoya T, Takeshima M, Ishikawa H, Kanbayashi T, Shimizu T.
Clinical Neuropsychopharmacology and Therapeutics. 9 1 - 2 2018.03 [Refereed]
Research paper (journal) Domestic Co-author
-
Omori Y.
Neuropsychiatric Disease and Treatment ( Neuropsychiatric Disease and Treatment ) 14 451 - 457 2018.02 [Refereed]
Research paper (journal) Domestic Co-author
-
Effects of aripiprazole for prolonged nocturnal sleep and delayed sleep phase disorder
Kanbayashi Takashi, Shimizu Tetsuo, Omori Yuki, Imanishi Aya, Takaki Manabu, Sagawa Youhei, Tsutsui Ko, Takeshima Masahiro, Ono Taisuke, Shiomi Toshiaki
Neurological Therapeutics ( Japanese Society of Neurological Therapeutics ) 34 ( 4 ) 406 - 410 2018 [Refereed]
Research paper (journal) Domestic Co-author
<p>Delayed sleep phase disorder (DSPD) comprises a persistent or recurrent pattern of sleep disturbances, sleep disruption that leads to insomnia and/or excessive daytime sleepiness, and impaired functioning in social, occupational, or other spheres. Three techniques are typically used to treat DSPD : chronotherapy, phototherapy, and exogenous melatonin administration. Antipsychotics have not been reported in the treatment of DSPD, aripiprazole (APZ), which is a second generation antipsychotic, manifests a novel mechanism of action by serving as a partial agonist of D2 receptors. Depression is reported to be the most common psychopathology associated with DSPD, and APZ is reported to be effective in major depressive disorder as adjunctive therapy. Therefore, we speculated that APZ might be effective to treat DSPD, and we observed how APZ works for the treatment of DSPD.</p><p>Methods : 18 subjects (including 7 women) who are 14–48–year–old (the average is 31.6) were included. The patients were prescribed 0.75–4.5mg APZ at once a day.</p><p>Results : We prescribed 1.5–3.0mg/day of APZ, all subject reduced total sleep time (9.6 +/− 2.3h → 7.8 +/− 2.0h, p=0.03), many cases got up earlier (9.1 +/− 1.9h → 6.7 +/− 1.4h, p=0.005) in the morning and advanced their sleep phase within one week. The sleep onset was not significantly changed (23.5 +/− 2.0h → 22.9 +/− 1.9h, n.s.).</p><p>Conclusion : Low dose of APZ would reduce nocturnal sleep time in the subjects who had prolonged sleep time and DSPD symptoms. The mechanism of action would be dopaminergic up regulation due to dopamine D3 agonistic activity. Since it is difficult for physicians to treat prolonged sleep time and DSPD symptoms, this medication would become a new therapeutic tool for these patients.</p>
-
Takahashi J.
Sleep and Biological Rhythms ( Sleep and Biological Rhythms ) 15 ( 3 ) 235 - 241 2017.07 [Refereed]
Research paper (journal) Domestic Co-author
-
Acute Respiratory Distress Syndrome and Lamotrigine: A Case Report
Takeshima M.
Psychosomatics ( Psychosomatics ) 58 ( 3 ) 313 - 316 2017.05 [Refereed]
Research paper (journal) Domestic Co-author
-
Lamotrigine-Induced Disseminated Intravascular Coagulation With Anticonvulsant Hypersensitivity Syndrome: A Case Report.
Takeshima M, Ishikawa H, Shimizu T, Toyoshima A, Manabe M.
Psychosomatics 57 ( 5 ) 540 - 542 2016.09 [Refereed]
Research paper (journal) Domestic Co-author